Synchron is pioneering minimally invasive brain-computer interfaces (BCIs) to restore communication, mobility, and independence for people with paralysis. Its Stentrode™ platform is the first endovascular BCI designed to translate thought into digital action without open-brain surgery, combining neurointerventional access, device engineering, and NeuroAI to create scalable, real-world neural interfaces.
Synchron had 131 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
131Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Synchron had 45,919 followers as of October 5, 2026. The number of followers increased by 154 (0.34%) week-over-week.
45,919Latest Followers Count
154(0.34%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.